ARCHIVES

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

This article is from The Cancer Letter archive.

Vol. 37 No. 14 | April 8, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Board Ok’s PA, BRM Contract Concepts

October 30, 1992

Study Finds That CTC Was Used Correctly In Medicare Patients

April 26, 2013

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010

NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period

October 18, 1985

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

Rauscher Explains Reasons for Treatment Switches

May 9, 1975